These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 27379554)
1. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients. Sullivan T; Weinberg A; Rana M; Patel G; Huprikar S Transplantation; 2016 Sep; 100(9):1939-43. PubMed ID: 27379554 [TBL] [Abstract][Full Text] [Related]
2. Liver graft failure and hyperbilirubinemia in liver transplantation recipients after Clostridium difficile infection. Rochon C; Kardashian A; Mahadevappa B; Gunasekaran G; Sharma J; Sheiner P Transplant Proc; 2011 Dec; 43(10):3819-23. PubMed ID: 22172853 [TBL] [Abstract][Full Text] [Related]
4. The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008. Feuerstadt P; Das R; Brandt LJ Am J Gastroenterol; 2014 Aug; 109(8):1265-76. PubMed ID: 25001255 [TBL] [Abstract][Full Text] [Related]
9. Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection. Kim SC; Seo MY; Lee JY; Kim KT; Cho E; Kim MG; Jo SK; Cho WY; Kim HK Korean J Intern Med; 2016 Jan; 31(1):125-33. PubMed ID: 26767866 [TBL] [Abstract][Full Text] [Related]
10. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study. Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients. Bruminhent J; Cawcutt KA; Thongprayoon C; Petterson TM; Kremers WK; Razonable RR Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28314071 [TBL] [Abstract][Full Text] [Related]
13. [Immunosuppressive treatment as a risk factor for the occurrence of clostridium difficile infection (CDI)]. Lübbert C; Johann C; Kekulé AS; Worlitzsch D; Weis S; Mössner J; Behl S; Seufferlein T Z Gastroenterol; 2013 Nov; 51(11):1251-8. PubMed ID: 23696115 [TBL] [Abstract][Full Text] [Related]
14. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for abdominal bleeding after living-donor liver transplant. Li C; Wen TF; Yan LN; Li B Exp Clin Transplant; 2014 Oct; 12(5):424-8. PubMed ID: 24568675 [TBL] [Abstract][Full Text] [Related]
16. [The incidence and clinical features of Clostridium difficile infection; single center study]. Lee JH; Lee SY; Kim YS; Park SW; Park SW; Jo SY; Ryu SH; Lee JH; Moon JS; Whang DH; Shin BM Korean J Gastroenterol; 2010 Mar; 55(3):175-82. PubMed ID: 20357528 [TBL] [Abstract][Full Text] [Related]
17. Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score. Tabak YP; Johannes RS; Sun X; Nunez CM; McDonald LC Infect Control Hosp Epidemiol; 2015 Jun; 36(6):695-701. PubMed ID: 25753106 [TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus. Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442 [TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes. Mittal C; Hassan S; Arshad S; Jeepalyam S; Bruni S; Miceli M; Jacobsen G; Abouljoud M; Bajjoka I; Ramesh M; Alangaden G Am J Transplant; 2014 Aug; 14(8):1901-7. PubMed ID: 24902610 [TBL] [Abstract][Full Text] [Related]
20. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Mattila E; Uusitalo-Seppälä R; Wuorela M; Lehtola L; Nurmi H; Ristikankare M; Moilanen V; Salminen K; Seppälä M; Mattila PS; Anttila VJ; Arkkila P Gastroenterology; 2012 Mar; 142(3):490-6. PubMed ID: 22155369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]